Evidence map›Paper›PMID 26416656›Full record

ArticleThe Journal of infectious diseases2016

Infectious Diseases Society of America and Gain-of-Function Experiments With Pathogens Having Pandemic Potential.

Gregory M Frank, Amesh Adalja, Alan Barbour, Arturo Casadevall, Philip R Dormitzer, Jeff Duchin, Frederick G Hayden, Martin S Hirsch, Noreen A Hynes, Marc Lipsitch and 2 more

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Gregory M FrankInfectious Diseases Society of America, Arlington.
Amesh AdaljaUPMC Center for Health Security, University of Pittsburgh Medical Center, Pennsylvania.
Alan BarbourDepartment of Medicine, University of California-Irvine Department of Microbiology and Molecular Genetics, University of California-Irvine.
Arturo CasadevallDepartment of Molecular Microbiology and Immunology, Baltimore, Maryland.
Philip R DormitzerNVS Influenza Vaccines, Cambridge.
Jeff DuchinPublic Health-Seattle and King County, Seattle University of Washington, Seattle.
Frederick G HaydenUniversity of Virginia School of Medicine, Charlottesville.
Martin S HirschDivision of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School.
Noreen A HynesCenter for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Marc LipsitchDepartment of Epidemiology, Center for Communicable Disease Dynamics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Andrew T PaviaDepartment of Pediatrics, Primary Children's Medical Center, University of Utah School of Medicine, Salt Lake City.
David A RelmanDepartment of Medicine, Center for International Security and Cooperation at Stanford University, California Department of Microbiology and Immunology, Center for International Security and Cooperation at Stanford University, California.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

RNA Virus InfectionsAnimalsBiomedical ResearchHumansPandemicsResearch Designgain-of-functionhealth policyinfluenzapotential pandemic pathogensscience policy

Identifiers

PMID26416656
PMCPMC7313907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.